70
Participants
Start Date
April 10, 2024
Primary Completion Date
January 31, 2025
Study Completion Date
April 30, 2025
Postbiotic ABB C3
A daily dose of 550 mg of the postbiotic blend ABB C3 in individual sachets for the first 3 months of the study.
Placebo
A daily dose of 550 mg of the placebo in individual sachets for the first 3 months of the study.
Follow-up Postbiotic ABB C3 (Optional)
Option given to all participants: a daily dose of 550 mg of the postbiotic blend ABB C3 in individual sachets for months 4 to 6 of the study.
RECRUITING
Hospital Sant Joan de Déu, Barcelona
Fundació Sant Joan de Déu
OTHER